Once-Daily Tiotropium Respimat Add-On to ICS+LABA Reduces Risk of Severe Exacerbation and Asthma Worsening in Patients With Asthma, Independent of Degree of Airflow Obstruction

Donald Tashkin; Petra Moroni-Zentgraf; Michael Engel; Hendrik Schmidt; Huib Kerstjens

首页> 外文期刊>Chest >Once-Daily Tiotropium Respimat Add-On to ICS+LABA Reduces Risk of Severe Exacerbation and Asthma Worsening in Patients With Asthma, Independent of Degree of Airflow Obstruction

【24h】

Once-Daily Tiotropium Respimat Add-On to ICS+LABA Reduces Risk of Severe Exacerbation and Asthma Worsening in Patients With Asthma, Independent of Degree of Airflow Obstruction

机译：ICS + LABA的每日一次噻托溴铵增效药可降低哮喘患者严重加重和哮喘恶化的风险，与气流阻塞程度无关

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Chest》 |2014年第4期|共页
作者
Donald Tashkin; Petra Moroni-Zentgraf; Michael Engel; Hendrik Schmidt; Huib Kerstjens;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO INHALED CORTICOSTEROIDS +/- LONG-ACTING beta(2)-AGONISTS IMPROVES LUNG FUNCTION AND ASTHMA CONTROL AND REDUCES RISK OF ASTHMA WORSENING IN PATIENTS WITH MODERATE OR SEVERE ASTHMA. [J] . Murphy K., Bensch G., Berger W. E., Annals of allergy, asthma, and immunology . 2014,第5Suppla1期

机译：对吸入的皮质类固醇激素+/-长期服用β（2）激动剂的一次补全性噻托溴铵（R）可改善肺功能和哮喘控制，并减轻中度或重度哮喘患者的哮喘恶化风险。
2. TIOTROPIUM RESPIMAT (R) ADD-ON THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH SYMPTOMATIC MODERATE TO SEVERE ASTHMA, INDEPENDENT OF T HELPER 2 STATUS [J] . Philips M., Casale T., Dahl R., Respirology : . 2016,第Suppla2期

机译：沙丁酸呼吸疗法（R）可以减轻症状中等至重度哮喘（独立于T HELPER 2状态的患者）的加重发作风险
3. Tiotropium respimat ? add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T H 2 inflammatory status [J] . WH Yang, T Casale, ED Bateman, Allergy, Asthma & Clinical Immunology . 2014,第SUPPLEMENTa2期

机译：噻托溴铵附加疗法可减轻有症状的中度哮喘患者的气流阻塞，与T H 2炎症状态无关
4. Tiotropium respimat® add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma independent of TH2 inflammatory status [O] . WH Yang, T Casale, ED Bateman, 2014

机译：噻托溴铵respimat®附加疗法可减轻有症状的中度哮喘患者的气流阻塞与TH2炎症状态无关
5. Tiotropium Respimat® Add-on to at Least Ics Therapy Demonstrates Reduced Risk of Severe Asthma Exacerbation and Asthma Worsening in Symptomatic Asthma, Independent of IgE or Blood Eosinophil Levels [O] . Thomas B. Casale, Donald P. Tashkin, Reinhold Lühmann, 2016

机译：TiotropiumRespimat®附加症至少ICS治疗表明，在症状性哮喘中严重哮喘恶化和哮喘恶化的风险降低，与IgE或血液粒细胞水平无关

Once-Daily Tiotropium Respimat Add-On to ICS+LABA Reduces Risk of Severe Exacerbation and Asthma Worsening in Patients With Asthma, Independent of Degree of Airflow Obstruction

著录项

相似文献

相关主题

期刊订阅